In particular explant studies have demonstrated higher AFP levels ≥200 ng/ml are associated with higher risk of both microvascular and macrovascular invasion, along with poorly differentiated tumours as was demonstrated in our analysis (Table 3) [21, 54]. This evidence concerns the gene AFP and neoplasm.